1–5 of 5 results for Thomas A. Ciulla
CD 46 is a Potent Complement Cofactor as Part of a Clinical Strategy for Geographic Atrophy
Thomas A. Ciulla, MD, MBA, FASRS
Updates from the Field
2026
“Real World” U.S. Outcomes of Anti-VEGF Therapy in Neovascular AMD: Risk of Vision Loss is Greatest in Patients with Better Baseline Visual Acuity
Annual Meeting Talks
2016
Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema
2017
Idiopathic Juxtafoveal Telangectasia Type 1
Retina Image Bank: Images of the Week
2015
RAP Lesions
2014